Results 81 to 90 of about 49,719 (230)

Supplementary Table 1 from HIV Infection and Survival of Lymphoma Patients in the Era of Highly Active Antiretroviral Therapy

open access: gold, 2023
Xuesong Han   +6 more
openalex   +1 more source

Enhanced Clearance of HIV‐1 Broadly Neutralizing Antibody VRC07‐523‐LS During Viremia: Influences on Trial Design and Analysis

open access: yesClinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT Broadly neutralizing antibodies (BNAb) are capable of neutralizing multiple HIV‐1 strains through the targeting of conserved epitopes. This study's objective was to quantify the pharmacokinetic (PK) parameters describing the distribution and elimination of the BNAb VRC07‐523‐LS in people with HIV (PWH), and to identify the influence of viral ...
Nicholas M. Smith   +14 more
wiley   +1 more source

A 5‐year longitudinal follow‐up study of serological responses to 23‐valent pneumococcal polysaccharide vaccination among patients with HIV infection who received highly active antiretroviral therapy* [PDF]

open access: bronze, 2009
Chien‐Ching Hung   +8 more
openalex   +1 more source

An Outlook on the Impact of HIV Infection and Highly Active Antiretroviral Therapy on the Cardiovascular System – A Review [PDF]

open access: diamond, 2020
Ishan Antony   +5 more
openalex   +1 more source

Predictors of discontinuing injectable cabotegravir/rilpivirine and virologic outcomes after resuming oral antiretroviral therapy

open access: yesHIV Medicine, Volume 27, Issue 2, Page 217-225, February 2026.
Abstract Objective Evaluate factors associated with discontinuation of long‐acting injectable (LAI) cabotegravir/rilpivirine (CAB/RPV) and describe virologic outcomes in those that returned to oral antiretroviral therapy (ART). Methods This is a retrospective cohort study at a single‐centre primary care HIV clinic.
Tali Faggiano   +6 more
wiley   +1 more source

Dyslipidemia in AIDS patients on highly active antiretroviral therapy

open access: yesBrazilian Journal of Infectious Diseases
Highly active antiretroviral therapy (HAART) reduces AIDS-related morbidity and mortality, however it has been associated with metabolic abnormalities. This study estimated the prevalence of lipid abnormalities and related factors among patients on HAART.
Max Weyler Nery   +2 more
doaj   +1 more source

Hansen's disease in association with immune reconstitution inflammatory syndrome

open access: yesIndian Dermatology Online Journal, 2016
Immune reconstitution inflammatory syndrome is characterized by a paradoxical worsening of an existing infection or disease process, soon after initiation of highly active antiretroviral therapy.
Anju George, Suja Vidyadharan
doaj   +1 more source

Effective communication and public engagement strategies to counter misinformation about infectious diseases

open access: yesImmunology &Cell Biology, Volume 104, Issue 2, Page 92-105, February 2026.
Public trust and cooperation in infectious disease control rest on three pillars: engagement, vaccine communication, and data presentation. Together, these foundations support resilient and inclusive public health responses to misinformation and uncertainty.
Sheena Cruickshank   +2 more
wiley   +1 more source

CD4 counts and the risk of systemic non-Hodgkin’s lymphoma in individuals with HIV in the UK

open access: yesHaematologica, 2009
Since the introduction of highly active antiretroviral therapy, there has been a decline in the incidence of non-Hodgkin’s lymphoma among HIV-infected individuals.
Mark Bower   +19 more
doaj   +1 more source

Etiologic Characteristics of Enterocolitis in Hospitalized HIV-Infected Patients for 3-Year Period (2013-2015)

open access: yesActa Medica Bulgarica, 2016
Diarrhea is the most common gastrointestinal symptom in HIV-infected patients. The incidence and severity of diarrhea increase with progression of the immune defi ciency.
Yancheva N.   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy